Scientists demonstrated that oxaliplatin induces RB1 phosphorylation, which is associated with the resistance to neoadjuvant oxaliplatin-based chemotherapy in locally advanced rectal cancer.
[Proceedings Of The National Academy Of Sciences Of The United States Of America]
